Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UKNOWN
UNII: 0XMR8L9LOL

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Lymphocyte differentiation antigen CD38 binding agent Other PubMed Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Myasthenia Gravis 2 D009157 ClinicalTrials
Purpura, Thrombocytopenic, Idiopathic 2 D016553 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Lupus Erythematosus, Systemic 1 D008180 ClinicalTrials
Autoimmune Diseases 1 D001327 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297833
FDA SRS 0XMR8L9LOL